Suzanne L. Nyemeck , Kenneth O. Eyong , Ronald Bidingha , Michael HK. Kamdem , Derek T. Ndinteh , Patricia O. Odumosu , Gabriel N. Folefoc , Danielle C. Bilanda , Andrew E. Egbe , Thomas Werner , Boris D. Bekono , Fidele Ntie-Kang
{"title":"设计、分离、合成和深入研究从蚕豆属植物中分离出的黄酮类化合物,将其作为潜在的 α-葡萄糖苷酶抑制剂","authors":"Suzanne L. Nyemeck , Kenneth O. Eyong , Ronald Bidingha , Michael HK. Kamdem , Derek T. Ndinteh , Patricia O. Odumosu , Gabriel N. Folefoc , Danielle C. Bilanda , Andrew E. Egbe , Thomas Werner , Boris D. Bekono , Fidele Ntie-Kang","doi":"10.1016/j.phytol.2024.06.004","DOIUrl":null,"url":null,"abstract":"<div><p>Flavonoids based on the flavone <strong>1–</strong>3 and a biflavanoid <strong>4</strong> with a flavan nucleus were isolated from <em>Beilschmiedia obscura</em> (Stapf). These compounds which include 5- hydroxy - 7,8-dimethoxyflavanone (<strong>5</strong>), (<em>2 S,4 R</em>)-5, 6,7-trimethoxyflavan-4-ol (<strong>6</strong>), beilschmieflavonoid B (<strong>7</strong>), (2 <em>R</em>,3 <em>S</em>)-5,6,7-trimethoxyflavan-3-ol (<strong>8</strong>), as well as pipyahyine (<strong>9</strong>), (<em>E</em>,<em>E</em>)-1,6-bis(4-hydroxy-3-methoxyphenyl) hexa-1,5-diene-3,4-dione (<strong>10</strong>), β-sitosterol (<strong>11</strong>), pentadecanoic acid (<strong>12</strong>), pentadecan-1-ol (<strong>13</strong>), stearic acid (<strong>14</strong>) and docosane-1,2,4-triol (<strong>15</strong>), were evaluated as α-glucosidase inhibitors. The most abundant compound <strong>5</strong>, was structurally modified by acetylation to compound <strong>16</strong> and NaBH<sub>4</sub> reduction to compound <strong>17</strong> which represent two new derivatives of this compound class. These compounds <strong>5–10</strong>, <strong>16–17</strong> including kaempferol <strong>18</strong>, and epicatechin <strong>19</strong> were screened for α-glucosidase from <em>Bacillus stearothermophyllus</em> and showed good inhibitory activity with IC<sub>50</sub> values = (30.55±0.12, 31.8±0.12, 32.47±0.17, 46.53±0.16, 36.43±0.12, 33, 48±0,12, 32.63±0.11 and 43.31±0.12 µM respectively) compared to acarbose (IC<sub>50</sub> = 63.77±0.08 µM) as reference drug. Molecular docking and SAR studies further confirmed the plausible binding interactions between the flavonoids and the enzyme α-glucosidase. The results show that these compounds bind effectively to the active site of the protein X-ray structure 3wy1, which is in accordance of the observed α-glucosidase inhibitory activity.</p></div>","PeriodicalId":20408,"journal":{"name":"Phytochemistry Letters","volume":"62 ","pages":"Pages 59-67"},"PeriodicalIF":1.3000,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Design, isolation, synthesis, and mechanistic insight of flavonoids isolated from Beilschmiedia obscura, as potential α-glucosidase inhibitors\",\"authors\":\"Suzanne L. Nyemeck , Kenneth O. Eyong , Ronald Bidingha , Michael HK. Kamdem , Derek T. Ndinteh , Patricia O. Odumosu , Gabriel N. Folefoc , Danielle C. Bilanda , Andrew E. Egbe , Thomas Werner , Boris D. Bekono , Fidele Ntie-Kang\",\"doi\":\"10.1016/j.phytol.2024.06.004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Flavonoids based on the flavone <strong>1–</strong>3 and a biflavanoid <strong>4</strong> with a flavan nucleus were isolated from <em>Beilschmiedia obscura</em> (Stapf). These compounds which include 5- hydroxy - 7,8-dimethoxyflavanone (<strong>5</strong>), (<em>2 S,4 R</em>)-5, 6,7-trimethoxyflavan-4-ol (<strong>6</strong>), beilschmieflavonoid B (<strong>7</strong>), (2 <em>R</em>,3 <em>S</em>)-5,6,7-trimethoxyflavan-3-ol (<strong>8</strong>), as well as pipyahyine (<strong>9</strong>), (<em>E</em>,<em>E</em>)-1,6-bis(4-hydroxy-3-methoxyphenyl) hexa-1,5-diene-3,4-dione (<strong>10</strong>), β-sitosterol (<strong>11</strong>), pentadecanoic acid (<strong>12</strong>), pentadecan-1-ol (<strong>13</strong>), stearic acid (<strong>14</strong>) and docosane-1,2,4-triol (<strong>15</strong>), were evaluated as α-glucosidase inhibitors. The most abundant compound <strong>5</strong>, was structurally modified by acetylation to compound <strong>16</strong> and NaBH<sub>4</sub> reduction to compound <strong>17</strong> which represent two new derivatives of this compound class. These compounds <strong>5–10</strong>, <strong>16–17</strong> including kaempferol <strong>18</strong>, and epicatechin <strong>19</strong> were screened for α-glucosidase from <em>Bacillus stearothermophyllus</em> and showed good inhibitory activity with IC<sub>50</sub> values = (30.55±0.12, 31.8±0.12, 32.47±0.17, 46.53±0.16, 36.43±0.12, 33, 48±0,12, 32.63±0.11 and 43.31±0.12 µM respectively) compared to acarbose (IC<sub>50</sub> = 63.77±0.08 µM) as reference drug. Molecular docking and SAR studies further confirmed the plausible binding interactions between the flavonoids and the enzyme α-glucosidase. The results show that these compounds bind effectively to the active site of the protein X-ray structure 3wy1, which is in accordance of the observed α-glucosidase inhibitory activity.</p></div>\",\"PeriodicalId\":20408,\"journal\":{\"name\":\"Phytochemistry Letters\",\"volume\":\"62 \",\"pages\":\"Pages 59-67\"},\"PeriodicalIF\":1.3000,\"publicationDate\":\"2024-07-08\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Phytochemistry Letters\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1874390024000934\",\"RegionNum\":4,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytochemistry Letters","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1874390024000934","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Design, isolation, synthesis, and mechanistic insight of flavonoids isolated from Beilschmiedia obscura, as potential α-glucosidase inhibitors
Flavonoids based on the flavone 1–3 and a biflavanoid 4 with a flavan nucleus were isolated from Beilschmiedia obscura (Stapf). These compounds which include 5- hydroxy - 7,8-dimethoxyflavanone (5), (2 S,4 R)-5, 6,7-trimethoxyflavan-4-ol (6), beilschmieflavonoid B (7), (2 R,3 S)-5,6,7-trimethoxyflavan-3-ol (8), as well as pipyahyine (9), (E,E)-1,6-bis(4-hydroxy-3-methoxyphenyl) hexa-1,5-diene-3,4-dione (10), β-sitosterol (11), pentadecanoic acid (12), pentadecan-1-ol (13), stearic acid (14) and docosane-1,2,4-triol (15), were evaluated as α-glucosidase inhibitors. The most abundant compound 5, was structurally modified by acetylation to compound 16 and NaBH4 reduction to compound 17 which represent two new derivatives of this compound class. These compounds 5–10, 16–17 including kaempferol 18, and epicatechin 19 were screened for α-glucosidase from Bacillus stearothermophyllus and showed good inhibitory activity with IC50 values = (30.55±0.12, 31.8±0.12, 32.47±0.17, 46.53±0.16, 36.43±0.12, 33, 48±0,12, 32.63±0.11 and 43.31±0.12 µM respectively) compared to acarbose (IC50 = 63.77±0.08 µM) as reference drug. Molecular docking and SAR studies further confirmed the plausible binding interactions between the flavonoids and the enzyme α-glucosidase. The results show that these compounds bind effectively to the active site of the protein X-ray structure 3wy1, which is in accordance of the observed α-glucosidase inhibitory activity.
期刊介绍:
Phytochemistry Letters invites rapid communications on all aspects of natural product research including:
• Structural elucidation of natural products
• Analytical evaluation of herbal medicines
• Clinical efficacy, safety and pharmacovigilance of herbal medicines
• Natural product biosynthesis
• Natural product synthesis and chemical modification
• Natural product metabolism
• Chemical ecology
• Biotechnology
• Bioassay-guided isolation
• Pharmacognosy
• Pharmacology of natural products
• Metabolomics
• Ethnobotany and traditional usage
• Genetics of natural products
Manuscripts that detail the isolation of just one new compound are not substantial enough to be sent out of review and are out of scope. Furthermore, where pharmacology has been performed on one new compound to increase the amount of novel data, the pharmacology must be substantial and/or related to the medicinal use of the producing organism.